Prevention of contrast-induced acute kidney injury in patients with stable chronic renal disease undergoing elective percutaneous coronary and peripheral interventions: Randomized comparison of two preventive strategies

Catheterization and Cardiovascular Interventions

Volumn 79, Issue 6, 2012, Pages 929-937

  Hafiz, Abdul Moiz ^a   Jan, M Fuad ^a   Mori, Naoyo ^b   Shaikh, Fareed ^a   Wallach, Jeffrey ^c   Bajwa, Tanvir ^a   Allaqaband, Suhail ^a  

^a AURORA SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF WISCONSIN MILWAUKEE   (United States)

^c ST LUKE S MEDICAL CENTER   (United States)

Author keywords

contrast; coronary; injury; intervention; kidney; nephropathy

Indexed keywords

ACETYLCYSTEINE; BICARBONATE; GLUCOSE; IODIXANOL; IOPAMIDOL; IOVERSOL; SODIUM CHLORIDE;

ADULT; AGE DISTRIBUTION; AGED; ARTERY CATHETERIZATION; ARTICLE; CHEMOPROPHYLAXIS; CHRONIC KIDNEY DISEASE; CONTRAST INDUCED NEPHROPATHY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; FEMALE; HUMAN; HYDRATION; INCIDENCE; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION;

ACETYLCYSTEINE; ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CATHETERIZATION, PERIPHERAL; CHI-SQUARE DISTRIBUTION; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; CREATININE; FEMALE; FLUID THERAPY; HEART CATHETERIZATION; HUMANS; INFUSIONS, INTRAVENOUS; KIDNEY DISEASES; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY; RISK ASSESSMENT; RISK FACTORS; SODIUM BICARBONATE; SODIUM CHLORIDE; TIME FACTORS; TREATMENT OUTCOME; VASCULAR DISEASES; WISCONSIN;

EID: 84860649602     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.23148     Document Type: Article

References (48)

1. Parfrey PS, Griffiths SM, Barrett BJ, Paul MD, Genge M, Withers J, Farid N, McManamon PJ,. Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study. N Engl J Med 1989; 320: 143-149.
2. Stevens MA, McCullough PA, Tobin KJ, Speck JP, Westveer DC, Guido-Allen DA, Timmis GC, O'Neill WW,. A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy: Results of the P.R.I.N.C.E. Study. Prevention of Radiocontrast Induced Nephropathy Clinical Evaluation. J Am Coll Cardiol 1999; 33: 403-411.
3. Solomon R, Werner C, Mann D, D'Elia J, Silva P,. Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents. N Engl J Med 1994; 331: 1416-1420.
4. Brown JR, Block CA, Malenka DJ, O'Connor GT, Schoolwerth AC, Thompson CA,. Sodium bicarbonate plus N-acetylcysteine prophylaxis: a meta-analysis. J Am Coll Cardiol Intverv 2009; 2: 1116-1124.
5. McCullough PA, Wolyn R, Rocher LL, Levin RN, O'Neill WW,. Acute renal failure after coronary intervention: Incidence, risk factors, and relationship to mortality. Am J Med 1997; 103: 368-375.
6. Brar SS, Hiremath S, Dangas G, Mehran R, Brar SK, Leon MB,. Sodium bicarbonate for the prevention of contrast induced-acute kidney injury: A systematic review and meta-analysis. Clin J Am Soc Nephrol 2009; 4: 1584-1592.
7. Nash K, Hafeez A, Hou S,. Hospital-acquired renal insufficiency. Am J Kidney Dis 2002; 39 (5): 930-936.
8. McCullough PA,. Contrast-induced acute kidney injury. J Am Coll Cardiol 2008; 51: 1419-1428.
9. Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W,. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 2000; 343: 180-184.
10. Solomon R, Dauerman HL,. Contrast-induced acute kidney injury. Circulation 2010; 122: 2451-2455.
11. Atkins JL,. Effect of sodium bicarbonate preloading on ischemic renal failure. Nephron 1986; 44: 70-74.
12. Hogan SE, L'Allier P, Chetcuti S, Grossman PM, Nallamothu BK, Duvernoy C, Bates E, Moscucci M, Gurm HS,. Current role of sodium bicarbonate-based preprocedural hydration for the prevention of contrast-induced acute kidney injury: a meta-analysis. Am Heart J 2008; 156: 414-421.
13. Navaneethan SD, Singh S, Appasamy S, Wing RE, Sehgal AR,. Sodium bicarbonate therapy for prevention of contrast-induced nephropathy: a systematic review and meta-analysis. Am J Kidney Dis 2009; 53: 617-627.
14. Brar SS, Shen AY, Jorgensen MB, Kotlewski A, Aharonian VJ, Desai N, Ree M, Shah AI, Burchette RJ,. Sodium bicarbonate vs sodium chloride for the prevention of contrast medium-induced nephropathy in patients undergoing coronary angiography: A randomized trial. JAMA 2008; 300: 1038-1046.
15. Briguori C, Airoldi F, D'Andrea D, Bonizzoni E, Morici N, Focaccio A, Michev I, Montorfano M, Carlino M, Cosgrave J, Ricciardelli B, Colombo A,. Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): A randomized comparison of three preventive strategies. Circulation 2007; 115: 1211-1217.
16. Merten GJ, Burgess WP, Gray LV, Holleman JH, Roush TS, Kowalchuk GJ, Bersin RM, Van Moore A, Simonton CA, III, Rittase RA, Norton HJ, Kennedy TP,. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA 2004; 291: 2328-2334.
17. Maioli M, Toso A, Leoncini M, Gallopin M, Tedeschi D, Micheletti C, Bellandi F,. Sodium bicarbonate versus saline for the prevention of contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. J Am Coll Cardiol 2008; 52: 599-604.
18. Maeder M, Klein M, Fehr T, Rickli H,. Contrast nephropathy: Review focusing on prevention. J Am Coll Cardiol 2004; 44: 1763-1771.
19. Meier P, Ko DT, Tamura A, Tamhane U, Gurm HS., Sodium bicarbonate-based hydration prevents contrast-induced nephropathy: A meta-analysis. BMC Med 2009; 7: 23.
20. Marenzi G, Assanelli E, Marana I, Lauri G, Campodonico J, Grazi M, De Metrio M, Galli S, Fabbiocchi F, Montorsi P, Veglia F, Bartorelli AL,. N-acetylcysteine and contrast-induced nephropathy in primary angioplasty. N Engl J Med 2006; 354: 2773-2782.
21. Dauerman HL,. In search of an algorithm to prevent acute kidney injury. J Am Card Cardiol Interv 2009; 2: 1125-1127.
22. Schmidt P, Pang D, Nykamp D, Knowlton G, Jia H,. N-acetylcysteine and sodium bicarbonate versus N-acetylcysteine and standard hydration for the prevention of radiocontrast-induced nephropathy following coronary angiography. Ann Pharmacother 2007; 41: 46-50.
23. From AM, Bartholmai BJ, Williams AW, Cha SS, Pflueger A, McDonald FS,. Sodium bicarbonate is associated with an increased incidence of contrast nephropathy: A retrospective cohort study of 7977 patients at Mayo Clinic. Clin J Am Soc Nephrol 2008; 3: 10-18.
24. Tumlin J, Stacul F, Adam A, Becker CR, Davidson C, Lameira N, McCullough PA,; CIN Consensus Working Panel. Pathophysiology of contrast-induced nephropathy. Am J Cardiol 2006; 98: 14K-20K.
25. Detrenis S, Meschi M, Musini S, Savazzi G,. Lights and shadows on the pathogenesis of contrast-induced nephropathy: state of the art. Nephrol Dial Transplant 2005; 20: 1542-1550.
26. Katholi RE, Woods WT Jr., Taylor GJ, Deitrick CL, Womack KA, Katholi CR, McCann WP,. Oxygen free radicals and contrast nephropathy. Am J Kidney Dis 1998; 32: 64-71.
27. Russo D, Minutolo R, Cianciaruso B, Memoli B, Conte G, De Nicola L,. Early effects of contrast media on renal hemodynamics and tubular function in chronic renal failure. J Am Soc Nephrol 1995; 6: 1451-1458.
28. Pannu N, Manns B, Lee H, Tonelli M,. Systematic review of the impact of N-acetylcysteine on contrast nephropathy. Kidney Int 2004; 65: 1366-1374.
29. Bagshaw SM, Ghali WA,. Acetylcysteine for prevention of contrast-induced nephropathy after intravascular angiography: A systematic review and meta-analysis. BMC Med 2004; 2: 38.
30. Liu R, Nair D, Ix J, Moore DH, Bent S,. N-acetylcysteine for the prevention of contrast-induced nephropathy. A systematic review and meta-analysis. J Gen Intern Med 2005; 20: 193-200.
31. Duong MH, MacKenzie TA, Malenka DJ,. N-acetylcysteine prophylaxis significantly reduces the risk of radiocontrast-induced nephropathy: Comprehensive meta-analysis. Catheter Cardiovasc Interv 2005; 64: 471-479.
32. Nallamothu BK, Shojania KG, Saint S, Hofer TP, Humes HD, Moscucci M, Bates ER,. Is acetylcysteine effective in preventing contrast-related nephropathy? A meta-analysis. Am J Med 2004; 117: 938-947.
33. Birck R, Krzossok S, Markowetz F, Schnülle P, van der Woude FJ, Braun C,. Acetylcysteine for prevention of contrast nephropathy: Meta-analysis. Lancet 2003; 362: 598-603.
34. Isenbarger DW, Kent SM, O'Malley PG,. Meta-analysis of randomized clinical trials on the usefulness of acetylcysteine for prevention of contrast nephropathy. Am J Cardiol 2003; 92: 1454-1458.
35. Alonso A, Lau J, Jaber BL, Weintraub A, Sarnak MJ,. Prevention of radiocontrast nephropathy with N-acetylcysteine in patients with chronic kidney disease: A meta-analysis of randomized, controlled trials. Am J Kidney Dis 2004; 43: 1-9.
36. Misra D, Leibowitz K, Gowda RM, Shapiro M, Khan IA,. Role of N-acetylcysteine in prevention of contrast-induced nephropathy after cardiovascular procedures: A meta-analysis. Clin Cardiol 2004; 27: 607-610.
37. Kshirsagar AV, Poole C, Mottl A, Shoham D, Franceschini N, Tudor G, Agrawal M, Denu-Ciocca C, Magnus Ohman E, Finn WF,. N-acetylcysteine for the prevention of radiocontrast induced nephropathy: A meta-analysis of prospective controlled trials. J Am Soc Nephrol 2004; 15: 761-769.
38. Allaqaband S, Tumuluri R, Malik AM, Gupta A, Volkert P, Shalev Y, Bajwa TK,. Prospective randomized study of N-acetylcysteine, fenoldopam, and saline for prevention of radiocontrast-induced nephropathy. Catheter Cardiovasc Interv 2002; 57: 279-283.
39. Fishbane S,. N-acetylcysteine in the prevention of contrast-induced nephropathy. Clin J Am Soc Nephrol 2008; 3: 281-287.
40. Durham JD, Caputo C, Dokko J, Zaharakis T, Pahlavan M, Keitz J, Dutka P, Marzo K, Maesaka JK, Fishbane S,. A randomized controlled trial of N-acetylcysteine to prevent contrast nephropathy in cardiac angiography. Kidney Int 2002; 62: 2202-2207.
41. The ACT Trial Investigators. Rationale, design, and baseline characteristics of the Acetylcystein for Contrast-Induced nephropaThy (ACT) Trial: A pragmatic randomized controlled trial to evaluate the efficacy of acetylcysteine for the prevention of contrast-induced nephropathy. Trials 2009; 10: 38.
42. Eisenberg RL, Bank WO, Hedgock MW,. Renal failure after major angiography can be avoided with hydration. AJR Am J Roentgenol 1981; 136: 859-861.
43. Mueller C, Buerkle G, Buettner HJ, Petersen J, Perruchoud AP, Eriksson U, Marsch S, Roskamm H,. Prevention of contrast media-associated nephropathy: randomized comparison of two hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med 2002; 162: 329-336.
44. McCullough PA, Soman SS,. Contrast-induced nephropathy. Crit Care Clin 2005; 21: 261-280.
45. Bartholomew BA, Harjai KJ, Dukkipati S, Boura JA, Yerkey MW, Glazier S, Grines CL, O'Neill WW,. Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. Am J Cardiol 2004; 93: 1515-1519.
46. Rihal CS, Textor SC, Grill DE, Berger PB, Ting HH, Best PJ, Singh M, Bell MR, Barsness GW, Mathew V, Garratt KN, Holmes DR, Jr,. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 2002; 105: 2259-2264.
47. Freeman RV, O'Donnell M, Share D, Meengs WL, Kline-Rogers E, Clark VL, DeFranco AC, Eagle KA, McGinnity JG, Patel K, Maxwell-Eward A, Bondie D, Moscucci M, Blue Cross-Blue Shield of Michigan Cardiovascular Consortium (BMC2). Nephropathy requiring dialysis after percutaneous coronary intervention and the critical role of an adjusted contrast dose. Am J Cardiol 2002; 90: 1068-1073.
48. Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, Mintz GS, Lansky AJ, Moses JW, Stone GW, Leon MB, Dangas G,. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: Development and initial validation. J Am Coll Cardiol 2004; 44: 1393-1399.